• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

SHAREHOLDER ALERT: ZEV BMRN RECAF: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

By: The Law Offices of Vincent Wong via AccessWire
November 05, 2021 at 16:45 PM EDT

NEW YORK, NY / ACCESSWIRE / November 5, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Lightning Emotors, Inc (NYSE: ZEV)
If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/lightning-emotors-inc-loss-submission-form?prid=20916&wire=1
Lead Plaintiff Deadline: December 15, 2021
Class Period: May 7, 2021 - August 16, 2021
Allegations against ZEV include that: (i) the Company would record a substantially greater net loss per share in the second quarter of 2021 compared to the second quarter of 2020 and would pull its full year guidance for the remainder of 2021; (ii) accordingly, the Company materially overstated its financial position and/or prospects; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN)
If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/biomarin-pharmaceutical-inc-loss-submission-form-2?prid=20916&wire=1
Lead Plaintiff Deadline: December 22, 2021
Class Period: January 13, 2020 - September 3, 2021
Allegations against BMRN include that: (i) BMN 307, an Adeno-Associated Virus Vector-Mediated Gene Transfer of Human Phenylalanine Hydroxylase, was less safe than BioMarin had led investors to believe; (ii) BMN 307's safety profile made it likely that the Food and Drug Administration would place a clinical hold on the Phearless Phase 1/2 study; (iii) accordingly, the Company had overstated BMN 307's clinical and commercial prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Reconnaissance Energy Africa Ltd. f/k/a Lund Enterprises Corp. (OTCMKT:RECAF)
If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/reconnaissance-energy-africa-ltd-f-k-a-lund-enterprises-corp-loss-submission-form?prid=20916&wire=1
Lead Plaintiff Deadline: December 27, 2021
Class Period: February 28, 2019 - September 7, 2021
Allegations against RECAF include that: (1) ReconAfrica's plan for using unconventional means for energy extraction (including fracking) in the fragile Kavango area; (2) ReconAfrica would begin unlicensed drilling tests; (3) ReconAfrica would illegally use water for well testing; (4) ReconAfrica would illegally store used water in unlined pools; (5) ReconAfrica would skirt Namibian law and hire an inadequate and inappropriate consultant; (6) as a result, ReconAfrica risked future well, drilling, and water-related licenses in Namibia and Botswana; (7) as opposed to its representations, ReconAfrica did not reach out nor provide adequate information (including in relevant local languages) through accessible means to those to be impacted by its testing and potential energy extraction; (8) ReconAfrica's interests are in the Owambo Basin, not the so-called Kavango Basin; (9) ReconAfrica has continuously engaged in stock pumping; and (10) as a result of the foregoing, Defendants' public statements were materially false and/or misleading at all relevant times.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong



View source version on accesswire.com:
https://www.accesswire.com/671488/SHAREHOLDER-ALERT-ZEV-BMRN-RECAF-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines

More News

View More
MarketBeat Week in Review – 10/13 - 10/17
Today 7:00 EDT
Via MarketBeat
Topics Artificial Intelligence Economy World Trade
Tickers ACHR AMZN APLD APP ASTS CRM
This AI Chip Giant Could Be the Market’s Next Big Winner
October 17, 2025
Via MarketBeat
Topics Artificial Intelligence
Tickers AMD TSM
Broadcom Inks OpenAI Deal: Why It's A Huge Win for AVGO Stock
October 17, 2025
Via MarketBeat
Topics Artificial Intelligence
Tickers AMD AVGO NVDA
Institutions Are Fueling CrowdStrike’s Next Leg Higher
October 17, 2025
Via MarketBeat
Topics Artificial Intelligence
Tickers CRWD DDOG ZS
Microsoft & NVIDIA Unveil GB300 Supercomputer as AI Race Heats Up
October 17, 2025
Via MarketBeat
Topics Artificial Intelligence
Tickers AMZN MSFT NVDA

Recent Quotes

View More
Symbol Price Change (%)
AMZN  213.04
-1.43 (-0.67%)
AAPL  252.29
+4.84 (1.96%)
AMD  233.08
-1.48 (-0.63%)
BAC  51.28
+0.84 (1.67%)
GOOG  253.79
+1.91 (0.76%)
META  716.91
+4.84 (0.68%)
MSFT  513.58
+1.97 (0.39%)
NVDA  183.22
+1.41 (0.78%)
ORCL  291.31
-21.69 (-6.93%)
TSLA  439.31
+10.56 (2.46%)
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap